As of November 6, 2026, Prokidney Corp. is a publicly traded company (Nasdaq: PROK). The largest holder reporting an active stake on Schedule 13D is Control Empresarial de Capitales S.A. de C.V., at 36%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D/A, April 30, 2026).
Is this your company?
About to sign with, pay or invest in Prokidney Corp.? See the free Snapshot first.
Free to see. No signup.
Is Prokidney Corp. a real, registered company?
- Prokidney Corp. files with the SEC under CIK 1850270 (its SEC filings).
- Its shares are listed under the ticker PROK on Nasdaq (SEC company record).
- Incorporated in E9; business address in Winston-Salem, North Carolina, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under PROKIDNEY CORP. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Control Empresarial de Capitales S.A. de C.V. (filed 2026-04-30).
Who are Prokidney Corp.'s owners and officers?
Prokidney Corp.: business address in Winston-Salem, North Carolina; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-12).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-12 | Morgan Stanley | 4.7% |
| Schedule 13D/A, 2026-04-30 | Control Empresarial De Capitales S.A. De C.V. | 36% |
| Schedule 13G, 2026-02-12 | Morgan Stanley | 6% |
| Schedule 13G/A, 2025-08-07 | Morgan Stanley | 4.4% |
| Schedule 13G/A, 2025-07-17 | Blackrock, Inc. | 1.4% |
Questions about who owns Prokidney Corp.
Who owns Prokidney Corp.?
On this page, one holder's latest ownership filing reports 5% or more of Prokidney Corp.: Control Empresarial De Capitales S.A. De C.V. (36%, Schedule 13D/A, filed 2026-04-30).
When did Control Empresarial De Capitales S.A. De C.V. buy into Prokidney Corp.?
The filings give report dates, not purchase dates. The earliest filing from Control Empresarial De Capitales S.A. De C.V. on this page is the Schedule 13D/A, filed 2026-04-30, reporting 36%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Prokidney Corp.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Prokidney Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Prokidney Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Prokidney Corp. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Control Empresarial de Capitales S.A. de C.V., a 10% owner: 73,842,723 shares (Form 4, 2026-04-30).
- Tolerantia, LLC, a 10% owner: 22,617,909 shares, held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-06-05).
- , a director and 10% owner: 22,617,909 shares, held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-06-05).
- , a 10% owner: 857,500 shares, 712,583 held directly and 144,917 indirectly (Form 3, 2024-10-22).
- , the chief legal officer: 327,713 shares (Form 4, 2026-06-15).
Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.
How much has Prokidney Corp. raised?
No fundraising or offering filing from Prokidney Corp. is on file with us.
Keep reading
More on Prokidney Corp. and the records around it.
Prokidney Corp. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/prokidney